The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

New Paradigms in Treatment of Venous Thromboembolism


     

   Subscribe/Renew Journal


Deep vein thrombosis (DVT) and pulmonary embolism (PE) are potentially serious clinical entities which can result in fatal outcome. Results of studies published have shown that DVT and PE (together referred as venous thromboembolism) in Indian patients are as much common as occurring amongst Western countries. Globally, incidence of VTE is 0.75-2.69 per 1000 population and in population 70 years or more incidence is 2-7 per 1000 population. However, the VTE risk perception amongst treating Indian physicians is variable and results in poor implementation of prophylaxis for thrombosis as compared to other countries. It has been reported that 53.6% of hospitalised patients (surgical 63.3%, medical 44.7%) were at risk of for VTE and more than 80% of these patients did not receive prophylaxis for VTE as recommended by American College of Physicians.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Pinjala RENDORSE-India investigators. Venous thromboembolism risk and prophylaxis in acute hospital care setting. a multinational cross sectional study : results from the Indian subset data. Indian J Med Res 2012;136:60-7

  • Raskob GE, Angchalsuksiri P, Blanco AN, Buller H, GallusA, Hunt BJ et al Thrombosis a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71

  • Cohen AT. Tapson VF,Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al Venous thromboembolism risk and prophylaxis an the acute hospital care setting( ENDORSE study): a multinational cross sectional study Lancet 2008;371:387-94

  • Schulman S, Lindmarker P, HO lmstrom M, Larfars G, Carlsson A, NicolP et al. Post thrombotic syndrome,recurrence and death 10 years after the first episode of venous thrombo embolism treated with warfarin for six weeks or six months J ThrombHaemost 2006;4:734-42

  • Kakkar N, Kaur R, John M Outpatient oral anticoagulant management –an audit of 82 patients J Assoc Physicians India 2005;53:847-52

  • Kakkar N, Kaur R Knowledge base of clinicians regarding oral anticoagulation therapy in teaching institution –a questionnaire survey J Assoc Physicians India 2004;52:868-72

  • Yeh CH, Gross PL, Weitz JL Evolving use of new oral anticoagulantsfor treatment of venous thromboembolism Blood 2014;124(7):1020-28

  • Moll S New insights into treatment of venous thromboembolism Hematology 2014;297-305

  • Waldron B,Moll S A patients guideto recovery after deep vein thrombosis or pulmonary embolism Circulation 2014;129(17):e 477-e479

  • Wells PS,Forgie MA,Rodger MA Treatment of venous thromboembolism JAMA 2014;311(7):717-28

  • CohenAT,ImfeldS,Rider T Phase III trials of new oral anticoagulants i the acute treatment and secondary prevention of VTE:comparison and critique of study methodology and results Adv Ther 2014;31(5): 473-93

  • Cushman M, Lim W, Zakai NA Clinical practice guide on anti thrombotic drug dosing and management of antithrombotic drug associated bleeding complications in adults http://www.hematology.org/ clinicians/guidelines-Quality/Quick-Ref/2869.aspx. September 14,2014

  • Pollack CV, Relly PA, Elkelboom J, et al Idarucizumab for dabigatran reversal N Engl J Med 2015;373:511-20

  • Kearan C, Omelas J, Blairas DO Anti thrombotic therapy for VTE disease Chest guidelines and expert panel report Chest 2016;149:315-52

  • Simes J, Becanttini C, Agnelli G et al Aspirin for prevention of recurrent venous thromboembolism : the INSPIRE collaboration Circulation 2014;130(130:106271

  • Mantha S, Karp R,Raghvan V et al Assessing the risk of venous thromboembolic events in women taking progestinonly cpntraception – a meta analysis BMJ 2012;345:e4944

  • Kahn SR, Shapiro S,Wells PS et al Compression stockings to prevent post thrombotic syndrome a randomised placebo controlled trial Lancet 2014; 383(9920):880-88


Abstract Views: 251

PDF Views: 0




  • New Paradigms in Treatment of Venous Thromboembolism

Abstract Views: 251  |  PDF Views: 0

Authors

Abstract


Deep vein thrombosis (DVT) and pulmonary embolism (PE) are potentially serious clinical entities which can result in fatal outcome. Results of studies published have shown that DVT and PE (together referred as venous thromboembolism) in Indian patients are as much common as occurring amongst Western countries. Globally, incidence of VTE is 0.75-2.69 per 1000 population and in population 70 years or more incidence is 2-7 per 1000 population. However, the VTE risk perception amongst treating Indian physicians is variable and results in poor implementation of prophylaxis for thrombosis as compared to other countries. It has been reported that 53.6% of hospitalised patients (surgical 63.3%, medical 44.7%) were at risk of for VTE and more than 80% of these patients did not receive prophylaxis for VTE as recommended by American College of Physicians.

References